Click for best price
Prophylactic Hepatitis B Virus Vaccines Market Size, Share 2022
The main objective of hepatitis B immunization strategies is to prevent chronic hepatitis B virus infection and its serious consequences, including liver cirrhosis and hepatocellular cancer.
This report contains market size and forecasts of Prophylactic Hepatitis B Virus Vaccines in Global, including the following market information:
Global Prophylactic Hepatitis B Virus Vaccines Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Prophylactic Hepatitis B Virus Vaccines market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Hepatitis B Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Prophylactic Hepatitis B Virus Vaccines include Merck, Sanofi Pasteur, Novartis, Pfizer and GlaxoSmithKline, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Prophylactic Hepatitis B Virus Vaccines companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Prophylactic Hepatitis B Virus Vaccines Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Prophylactic Hepatitis B Virus Vaccines Market Segment Percentages, by Type, 2021 (%)
Hepatitis B
Liver Cirrhosis
Hepatocellular Carcinoma
Liver Failure
Global Prophylactic Hepatitis B Virus Vaccines Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Prophylactic Hepatitis B Virus Vaccines Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinics
Global Prophylactic Hepatitis B Virus Vaccines Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Prophylactic Hepatitis B Virus Vaccines Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Prophylactic Hepatitis B Virus Vaccines revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Prophylactic Hepatitis B Virus Vaccines revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Merck
Sanofi Pasteur
Novartis
Pfizer
GlaxoSmithKline
| Report Attributes |
Report Details |
| Report Title |
Prophylactic Hepatitis B Virus Vaccines Market, Global Outlook and Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
63 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Prophylactic Hepatitis B Virus Vaccines Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Prophylactic Hepatitis B Virus Vaccines Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Prophylactic Hepatitis B Virus Vaccines Overall Market Size
2.1 Global Prophylactic Hepatitis B Virus Vaccines Market Size: 2021 VS 2028
2.2 Global Prophylactic Hepatitis B Virus Vaccines Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Prophylactic Hepatitis B Virus Vaccines Players in Global Market
3.2 Top Global Prophylactic Hepatitis B Virus Vaccines Companies Ranked by Revenue
3.3 Global Prophylactic Hepatitis B Virus Vaccines Revenue by Companies
3.4 Top 3 and Top 5 Prophylactic Hepatitis B Virus Vaccines Companies in Global Market, by Revenue in 2021
3.5 Global Companies Prophylactic Hepatitis B Virus Vaccines Product Type
3.6 Tier 1, Tier 2 and Tier 3 Prophylactic Hepatitis B Virus Vaccines Players in Global Market
3.6.1 List of Global Tier 1 Prophylactic Hepatitis B Virus Vaccines Companies
3.6.2 List of Global Tier 2 and Tier 3 Prophylactic Hepatitis B Virus Vaccines Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Prophylactic Hepatitis B Virus Vaccines Market Size Markets, 2021 & 2028
4.1.2 Hepatitis B
4.1.3 Liver Cirrhosis
4.1.4 Hepatocellular Carcinoma
4.1.5 Liver Failure
4.2 By Type - Global Prophylactic Hepatitis B Virus Vaccines Revenue & Forecasts
4.2.1 By Type - Global Prophylactic Hepatitis B Virus Vaccines Revenue, 2017-2022
4.2.2 By Type - Global Prophylactic Hepatitis B Virus Vaccines Revenue, 2023-2028
4.2.3 By Type - Global Prophylactic Hepatitis B Virus Vaccines Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Prophylactic Hepatitis B Virus Vaccines Market Size, 2021 & 2028
5.1.2 Hospitals
5.1.3 Clinics
5.2 By Application - Global Prophylactic Hepatitis B Virus Vaccines Revenue & Forecasts
5.2.1 By Application - Global Prophylactic Hepatitis B Virus Vaccines Revenue, 2017-2022
5.2.2 By Application - Global Prophylactic Hepatitis B Virus Vaccines Revenue, 2023-2028
5.2.3 By Application - Global Prophylactic Hepatitis B Virus Vaccines Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Prophylactic Hepatitis B Virus Vaccines Market Size, 2021 & 2028
6.2 By Region - Global Prophylactic Hepatitis B Virus Vaccines Revenue & Forecasts
6.2.1 By Region - Global Prophylactic Hepatitis B Virus Vaccines Revenue, 2017-2022
6.2.2 By Region - Global Prophylactic Hepatitis B Virus Vaccines Revenue, 2023-2028
6.2.3 By Region - Global Prophylactic Hepatitis B Virus Vaccines Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Prophylactic Hepatitis B Virus Vaccines Revenue, 2017-2028
6.3.2 US Prophylactic Hepatitis B Virus Vaccines Market Size, 2017-2028
6.3.3 Canada Prophylactic Hepatitis B Virus Vaccines Market Size, 2017-2028
6.3.4 Mexico Prophylactic Hepatitis B Virus Vaccines Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Prophylactic Hepatitis B Virus Vaccines Revenue, 2017-2028
6.4.2 Germany Prophylactic Hepatitis B Virus Vaccines Market Size, 2017-2028
6.4.3 France Prophylactic Hepatitis B Virus Vaccines Market Size, 2017-2028
6.4.4 U.K. Prophylactic Hepatitis B Virus Vaccines Market Size, 2017-2028
6.4.5 Italy Prophylactic Hepatitis B Virus Vaccines Market Size, 2017-2028
6.4.6 Russia Prophylactic Hepatitis B Virus Vaccines Market Size, 2017-2028
6.4.7 Nordic Countries Prophylactic Hepatitis B Virus Vaccines Market Size, 2017-2028
6.4.8 Benelux Prophylactic Hepatitis B Virus Vaccines Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Prophylactic Hepatitis B Virus Vaccines Revenue, 2017-2028
6.5.2 China Prophylactic Hepatitis B Virus Vaccines Market Size, 2017-2028
6.5.3 Japan Prophylactic Hepatitis B Virus Vaccines Market Size, 2017-2028
6.5.4 South Korea Prophylactic Hepatitis B Virus Vaccines Market Size, 2017-2028
6.5.5 Southeast Asia Prophylactic Hepatitis B Virus Vaccines Market Size, 2017-2028
6.5.6 India Prophylactic Hepatitis B Virus Vaccines Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Prophylactic Hepatitis B Virus Vaccines Revenue, 2017-2028
6.6.2 Brazil Prophylactic Hepatitis B Virus Vaccines Market Size, 2017-2028
6.6.3 Argentina Prophylactic Hepatitis B Virus Vaccines Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Prophylactic Hepatitis B Virus Vaccines Revenue, 2017-2028
6.7.2 Turkey Prophylactic Hepatitis B Virus Vaccines Market Size, 2017-2028
6.7.3 Israel Prophylactic Hepatitis B Virus Vaccines Market Size, 2017-2028
6.7.4 Saudi Arabia Prophylactic Hepatitis B Virus Vaccines Market Size, 2017-2028
6.7.5 UAE Prophylactic Hepatitis B Virus Vaccines Market Size, 2017-2028
7 Players Profiles
7.1 Merck
7.1.1 Merck Corporate Summary
7.1.2 Merck Business Overview
7.1.3 Merck Prophylactic Hepatitis B Virus Vaccines Major Product Offerings
7.1.4 Merck Prophylactic Hepatitis B Virus Vaccines Revenue in Global Market (2017-2022)
7.1.5 Merck Key News
7.2 Sanofi Pasteur
7.2.1 Sanofi Pasteur Corporate Summary
7.2.2 Sanofi Pasteur Business Overview
7.2.3 Sanofi Pasteur Prophylactic Hepatitis B Virus Vaccines Major Product Offerings
7.2.4 Sanofi Pasteur Prophylactic Hepatitis B Virus Vaccines Revenue in Global Market (2017-2022)
7.2.5 Sanofi Pasteur Key News
7.3 Novartis
7.3.1 Novartis Corporate Summary
7.3.2 Novartis Business Overview
7.3.3 Novartis Prophylactic Hepatitis B Virus Vaccines Major Product Offerings
7.3.4 Novartis Prophylactic Hepatitis B Virus Vaccines Revenue in Global Market (2017-2022)
7.3.5 Novartis Key News
7.4 Pfizer
7.4.1 Pfizer Corporate Summary
7.4.2 Pfizer Business Overview
7.4.3 Pfizer Prophylactic Hepatitis B Virus Vaccines Major Product Offerings
7.4.4 Pfizer Prophylactic Hepatitis B Virus Vaccines Revenue in Global Market (2017-2022)
7.4.5 Pfizer Key News
7.5 GlaxoSmithKline
7.5.1 GlaxoSmithKline Corporate Summary
7.5.2 GlaxoSmithKline Business Overview
7.5.3 GlaxoSmithKline Prophylactic Hepatitis B Virus Vaccines Major Product Offerings
7.5.4 GlaxoSmithKline Prophylactic Hepatitis B Virus Vaccines Revenue in Global Market (2017-2022)
7.5.5 GlaxoSmithKline Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Prophylactic Hepatitis B Virus Vaccines Market Opportunities & Trends in Global Market
Table 2. Prophylactic Hepatitis B Virus Vaccines Market Drivers in Global Market
Table 3. Prophylactic Hepatitis B Virus Vaccines Market Restraints in Global Market
Table 4. Key Players of Prophylactic Hepatitis B Virus Vaccines in Global Market
Table 5. Top Prophylactic Hepatitis B Virus Vaccines Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Prophylactic Hepatitis B Virus Vaccines Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Prophylactic Hepatitis B Virus Vaccines Revenue Share by Companies, 2017-2022
Table 8. Global Companies Prophylactic Hepatitis B Virus Vaccines Product Type
Table 9. List of Global Tier 1 Prophylactic Hepatitis B Virus Vaccines Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Prophylactic Hepatitis B Virus Vaccines Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Prophylactic Hepatitis B Virus Vaccines Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Prophylactic Hepatitis B Virus Vaccines Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Prophylactic Hepatitis B Virus Vaccines Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Prophylactic Hepatitis B Virus Vaccines Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Prophylactic Hepatitis B Virus Vaccines Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Prophylactic Hepatitis B Virus Vaccines Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Prophylactic Hepatitis B Virus Vaccines Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Prophylactic Hepatitis B Virus Vaccines Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Prophylactic Hepatitis B Virus Vaccines Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Prophylactic Hepatitis B Virus Vaccines Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Prophylactic Hepatitis B Virus Vaccines Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Prophylactic Hepatitis B Virus Vaccines Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Prophylactic Hepatitis B Virus Vaccines Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Prophylactic Hepatitis B Virus Vaccines Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Prophylactic Hepatitis B Virus Vaccines Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Prophylactic Hepatitis B Virus Vaccines Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Prophylactic Hepatitis B Virus Vaccines Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Prophylactic Hepatitis B Virus Vaccines Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Prophylactic Hepatitis B Virus Vaccines Revenue, (US$, Mn), 2023-2028
Table 30. Merck Corporate Summary
Table 31. Merck Prophylactic Hepatitis B Virus Vaccines Product Offerings
Table 32. Merck Prophylactic Hepatitis B Virus Vaccines Revenue (US$, Mn), (2017-2022)
Table 33. Sanofi Pasteur Corporate Summary
Table 34. Sanofi Pasteur Prophylactic Hepatitis B Virus Vaccines Product Offerings
Table 35. Sanofi Pasteur Prophylactic Hepatitis B Virus Vaccines Revenue (US$, Mn), (2017-2022)
Table 36. Novartis Corporate Summary
Table 37. Novartis Prophylactic Hepatitis B Virus Vaccines Product Offerings
Table 38. Novartis Prophylactic Hepatitis B Virus Vaccines Revenue (US$, Mn), (2017-2022)
Table 39. Pfizer Corporate Summary
Table 40. Pfizer Prophylactic Hepatitis B Virus Vaccines Product Offerings
Table 41. Pfizer Prophylactic Hepatitis B Virus Vaccines Revenue (US$, Mn), (2017-2022)
Table 42. GlaxoSmithKline Corporate Summary
Table 43. GlaxoSmithKline Prophylactic Hepatitis B Virus Vaccines Product Offerings
Table 44. GlaxoSmithKline Prophylactic Hepatitis B Virus Vaccines Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Prophylactic Hepatitis B Virus Vaccines Segment by Type in 2021
Figure 2. Prophylactic Hepatitis B Virus Vaccines Segment by Application in 2021
Figure 3. Global Prophylactic Hepatitis B Virus Vaccines Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Prophylactic Hepatitis B Virus Vaccines Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Prophylactic Hepatitis B Virus Vaccines Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Prophylactic Hepatitis B Virus Vaccines Revenue in 2021
Figure 8. By Type - Global Prophylactic Hepatitis B Virus Vaccines Revenue Market Share, 2017-2028
Figure 9. By Application - Global Prophylactic Hepatitis B Virus Vaccines Revenue Market Share, 2017-2028
Figure 10. By Region - Global Prophylactic Hepatitis B Virus Vaccines Revenue Market Share, 2017-2028
Figure 11. By Country - North America Prophylactic Hepatitis B Virus Vaccines Revenue Market Share, 2017-2028
Figure 12. US Prophylactic Hepatitis B Virus Vaccines Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Prophylactic Hepatitis B Virus Vaccines Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Prophylactic Hepatitis B Virus Vaccines Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Prophylactic Hepatitis B Virus Vaccines Revenue Market Share, 2017-2028
Figure 16. Germany Prophylactic Hepatitis B Virus Vaccines Revenue, (US$, Mn), 2017-2028
Figure 17. France Prophylactic Hepatitis B Virus Vaccines Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Prophylactic Hepatitis B Virus Vaccines Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Prophylactic Hepatitis B Virus Vaccines Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Prophylactic Hepatitis B Virus Vaccines Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Prophylactic Hepatitis B Virus Vaccines Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Prophylactic Hepatitis B Virus Vaccines Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Prophylactic Hepatitis B Virus Vaccines Revenue Market Share, 2017-2028
Figure 24. China Prophylactic Hepatitis B Virus Vaccines Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Prophylactic Hepatitis B Virus Vaccines Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Prophylactic Hepatitis B Virus Vaccines Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Prophylactic Hepatitis B Virus Vaccines Revenue, (US$, Mn), 2017-2028
Figure 28. India Prophylactic Hepatitis B Virus Vaccines Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Prophylactic Hepatitis B Virus Vaccines Revenue Market Share, 2017-2028
Figure 30. Brazil Prophylactic Hepatitis B Virus Vaccines Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Prophylactic Hepatitis B Virus Vaccines Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Prophylactic Hepatitis B Virus Vaccines Revenue Market Share, 2017-2028
Figure 33. Turkey Prophylactic Hepatitis B Virus Vaccines Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Prophylactic Hepatitis B Virus Vaccines Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Prophylactic Hepatitis B Virus Vaccines Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Prophylactic Hepatitis B Virus Vaccines Revenue, (US$, Mn), 2017-2028
Figure 37. Merck Prophylactic Hepatitis B Virus Vaccines Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Sanofi Pasteur Prophylactic Hepatitis B Virus Vaccines Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Novartis Prophylactic Hepatitis B Virus Vaccines Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Pfizer Prophylactic Hepatitis B Virus Vaccines Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. GlaxoSmithKline Prophylactic Hepatitis B Virus Vaccines Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
